+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Preclinical Development"

Preclinical Assets Market Report 2025 - Product Thumbnail Image

Preclinical Assets Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Clinical Trial Supplies Market Report 2024-2034 - Product Thumbnail Image

Clinical Trial Supplies Market Report 2024-2034

  • Report
  • March 2024
  • 373 Pages
  • Global
From
From
From
From
From
Global mRNA Cancer Vaccines Clinical Trials & Market Future Outlook 2024 - Product Thumbnail Image

Global mRNA Cancer Vaccines Clinical Trials & Market Future Outlook 2024

  • Drug Pipelines
  • June 2024
  • 160 Pages
  • Global
From
From
STAT3 Inhibitors Market Opportunity & Clinical Trials Insight 2028 - Product Thumbnail Image

STAT3 Inhibitors Market Opportunity & Clinical Trials Insight 2028

  • Report
  • February 2025
  • 100 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

Preclinical Development is a critical step in the drug discovery process. It involves the testing of potential drugs on animals and in vitro systems to assess their safety and efficacy. This stage of development is used to identify potential risks and to determine the optimal dose and route of administration. Preclinical Development also includes the development of manufacturing processes and the evaluation of drug stability. The Preclinical Development market is highly competitive and consists of a variety of companies, ranging from large pharmaceutical companies to small biotechnology firms. These companies provide services such as drug discovery, preclinical testing, and manufacturing process development. They also offer consulting services to help clients navigate the drug development process. Some of the major players in the Preclinical Development market include Charles River Laboratories, WuXi AppTec, Covance, Parexel, and Syngene. Show Less Read more